Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan J de Gier

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Clinical Pharmacy|September 11, 2014
A study comparing the effectiveness of three warning labels on the package of driving-impairing medicinesBas Emich, Liset van Dijk, Susana P Monteiro, et al.
Traffic Injury Prevention|July 28, 2004
Drugs and drivingJ Michael Walsh, Johan J de Gier, Asbjørg S Christopherson, et al.
Informatics in Primary Care|March 18, 2014
Development of a web-based pharmaceutical care plan to facilitate collaboration between healthcare providers and patientsMarlies M E Geurts, Martijn Ivens, Egbert van Gelder, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic reviewMarlies M E Geurts, Jaap Talsma, Jacobus R B J Brouwers, et al.
Forensic Science International|June 29, 2014
Prevalence of medicinal drugs in suspected impaired drivers and a comparison with the use in the general Dutch populationKarlijn D B Bezemer, Beitske E Smink, Rianne van Maanen, et al.
Clinical Therapeutics|May 5, 2012
Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?Silvia Ravera, Johannes G Ramaekers, Lolkje T W de Jong-van den Berg, et al.
Clinical Therapeutics|March 1, 2011
Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005Silvia Ravera, Sipke T Visser, Johan J de Gier, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Road traffic accidents and psychotropic medication use in The Netherlands: a case-control studySilvia Ravera, Nienke van Rein, Johan J de Gier, et al.
Traffic Injury Prevention|February 28, 2013
How effective are pictograms in communicating risk about driving-impairing medicines?Susana P Monteiro, René Huiskes, Liset Van Dijk, et al.
European Journal of Epidemiology|May 12, 2012
A comparison of pharmacoepidemiological study designs in medication use and traffic safety researchSilvia Ravera, Nienke van Rein, Johan J de Gier, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Clinical Pharmacy|September 11, 2014
A study comparing the effectiveness of three warning labels on the package of driving-impairing medicinesBas Emich, Liset van Dijk, Susana P Monteiro, et al.
Traffic Injury Prevention|July 28, 2004
Drugs and drivingJ Michael Walsh, Johan J de Gier, Asbjørg S Christopherson, et al.
Informatics in Primary Care|March 18, 2014
Development of a web-based pharmaceutical care plan to facilitate collaboration between healthcare providers and patientsMarlies M E Geurts, Martijn Ivens, Egbert van Gelder, et al.
British Journal of Clinical Pharmacology|January 17, 2012
Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic reviewMarlies M E Geurts, Jaap Talsma, Jacobus R B J Brouwers, et al.
Forensic Science International|June 29, 2014
Prevalence of medicinal drugs in suspected impaired drivers and a comparison with the use in the general Dutch populationKarlijn D B Bezemer, Beitske E Smink, Rianne van Maanen, et al.
Clinical Therapeutics|May 5, 2012
Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?Silvia Ravera, Johannes G Ramaekers, Lolkje T W de Jong-van den Berg, et al.
Clinical Therapeutics|March 1, 2011
Prevalence, cumulative incidence, monotherapy and combination therapy, and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005Silvia Ravera, Sipke T Visser, Johan J de Gier, et al.
British Journal of Clinical Pharmacology|April 20, 2011
Road traffic accidents and psychotropic medication use in The Netherlands: a case-control studySilvia Ravera, Nienke van Rein, Johan J de Gier, et al.
Traffic Injury Prevention|February 28, 2013
How effective are pictograms in communicating risk about driving-impairing medicines?Susana P Monteiro, René Huiskes, Liset Van Dijk, et al.
European Journal of Epidemiology|May 12, 2012
A comparison of pharmacoepidemiological study designs in medication use and traffic safety researchSilvia Ravera, Nienke van Rein, Johan J de Gier, et al.
Pageof 3